The Application of Neuropathic Pain Questionnaires in Burning Mouth Syndrome Patients

Aims: To evaluate and compare the validity of the PainDETECT, DN4, and abbreviated DN4 (DN4i) neuropathic pain questionnaires for primary burning mouth syndrome (BMS), which is a burning sensation in the oral mucosa in the absence of any identifiable organic etiology. Methods: Eighty-one patients (42 with primary BMS and 39 with nociceptive pain) complaining of a burning sensation and pain in their oral mucosa were enrolled in this study. All of the patients completed the neuropathic pain questionnaires. The sensitivity, specificity, positive predictive value, negative predictive value, and the area under the receiver operating characteristic (ROC) curve were estimated. Then the relationship between pain intensity and total neuropathic pain score was investigated. Data were analyzed with the chi-square test and independent t test for subjects' baseline characteristic differences, and with Pearson correlation coefficients for the relationship of variables. Results: The mean area under the ROC curves (AUCs) for PainDETECT, DN4, and DN4i were 0.81, 0.79, and 0.81, respectively. There was no statistically significant difference in the AUCs among the questionnaires. PainDETECT, DN4, and DN4i had a lower sensitivity and specificity for BMS compared to previous validation studies. The total scores for PainDETECT, DN4, and DN4i in the primary BMS group were significantly associated with pain intensity. Conclusion: Although the results of this study suggest that neuropathic pain questionnaires, such as PainDETECT and DN4, are not ideal principal screening tools for BMS patients, a substantial proportion of neuropathic symptoms in primary BMS patients were identified.

burning mouth syndrome; DN4; neuropathic pain questionnaire; PainDETECT

1. Lipton JA, Ship JA, Larash-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc 1993;124:115–121.

2. Tammiala-salonen T, Hiidenkari T, Parvinen T. Burning mouth in a Finnish adult population. Community Dent Oral Epidemiol 1993;21:67–71.

3. Femiano F. Statistical survey of afferent pathologies during a 5- year study in the Oral Pathology Department at the Second University of Naples. Minerva Stomatol 2002;51:73–78.

4. Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2005;1:CD002779.

5. Bergdahl M, Bergdahl J. Burning mouth syndrome: Prevalence and associated factors. J Oral Pathol Med 1999;28:350–354.

6. Lamey PJ, Hobson RS, Orchardson R. Perception of stimulus size in patients burning mouth syndrome. J Oral Pathol Med 1996;25:420–423.

7. Ship JA, Grushka M, Lipton JA, Mott AE, Sessle BJ, Dionne RA. Burning mouth syndrome: An update. J Am Dent Assoc 1995;126:842–853.

8. Woda A, Dao T, Gremeau-Richard C. Steroid dysregulation and stomatodynia (burning mouth syndrome). J Orofac Pain 2009; 23:202–210.

9. Jääskeläinen SK, Forssell H, Tenovuo O. Abnormalities of the blink reflex in burning mouth syndrome. Pain 1997;73:455–460.

10. Forssell H, Jääskeläinen SK, Tenovuo O, Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain 2002;99:41–47.

11. Gao S, Wang Y, Wang Z. Assessment of trigeminal somatosensory evoked potentials in burning mouth syndrome. Chin J Dent Res 2000;3:40–46.

12. Lauria G, Majorana A, Borgna M, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005; 115:332–337.

13. Lauria G. Small fibre neuropathies. Curr Opin Neurol 2005;18: 591–597.

14. Hagelberg N, Forssell H, Rinne JO, et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain 2003; 101:149–154.

15. Jääskeläinen SK, Rinne JO, Forssell H, et al. Role of the dopaminergic system in chronic pain—A fluorodopa-PET study. Pain 2001;90:257–260.

16. Albuquerque RJ, de Leeuw R, Carlson CR, Okeson JP, Miller CS, Andersen AH. Cerebral activation during thermal stimulation of patients who have burning mouth disorder: An fMRI study. Pain 2006;122:223–234.

17. Jääskeläinen SK. Pathophysiology of primary burning mouth syndrome. Clin Neurophys 2012;123:71–77.

18. Bennett MI, Attal N, Backonja MM, et al. Using screening tools to identify neuropathic pain. Pain 2007;127:199–203.

19. Freynhagen R, Baron R, Gockel U, Tölle TR. PainDETECT: A new screening questionnaire to identify neuropathic pain components in patients with back pain. Curr Med Res Opin 2006; 22:1911–1920.

20. Bouhassira D, Attal N, Alchaar H, et al. Comparision of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114:29–36.

21. Danhauer SC, Miller CS, Rhodus NL, Carlson CR. Impact of criteria-based diagnosis of burning mouth syndrome on treat-ment outcome. J Orofac Pain 2002;16:305–311.

22. Gurvits GE, Tan A. Burning mouth syndrome. World J Gastroenterol 2013;19:665–672.

23. Cruccu G, Anand P, Attal N, et al. EFNS guidelines on neuro-pathic pain assessment. Eur J Neurol 2004;11:153–162.

24. Cruccu G, Aminoff MJ, Curio G, et al. Recommendations for the clinical use of somatosensory-evoked potentials. Clin Neurophysiol 2008;119:1705–1719.

25. Amris K, Jespersen A, Bliddal H. Self-reported somatosensory symptoms of neuropathic pain in fibromyalgia and chronic widespread pain correlate with tender point count and pres-sure-pain thresholds. Pain 2011;151:664–669.

26. Hochman JR, Gagliese L, Davis AM, Hawker GA. Neuropathic pain symptoms in a community knee OA cohort. Osteoarthritis Cartilage 2011;19:647–654.

27. Shigemura T, Ohtori S, Kishida S, et al. Neuropathic pain in patients with osteoarthritis of hip joint. Eur Orthop Traumatol 2011;2:73–77.

28. Jespersen A, Amris K, Bliddal H, et al. Is neuropathic pain underdiagnosed in musculoskeletal pain conditions? The Danish PainDETECTive study. Curr Med Res Opin 2010;26: 2041–2045.

29. Delong ER, Delong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988;44:837–845.

30. De Tommaso M, Lavolpe V, Di Venere D, et al. A case of unilateral burning mouth syndrome of neuropathic origin. Headache 2011;51:441–444.

31. Braud A, Touré B, Agbo-Godeau S, Descroix V, Boucher Y. Characteristics of pain assessed with visual analog scale and questionnaire in burning mouth syndrome patients: A pilot study. J Orofac Pain 2013;27:235–242.

32. Ukwas A, Zakrzewska J, Leeson R. An exploration of the pain-DETECT questionnaire as a potential screening tool in oro-fa-cial pain. Br J Pain 2012;6:24.

33. Elias LA, Yilmaz Z, Smith JG, Bouchiba M, et al. PainDETECT: A suitable screening tool for neuropathic pain in patients withpainful post-traumatic trigeminal nerve injuries? Int J Oral Maxillofac Surg 2013 Aug 6. doi:10.1016/j.ijom.2013.07.004.[Epub of ahead print]

34. Bouhassira D, Attal N. Diagnosis and assessment of neuropathic pain: The saga of clinical tools. Pain 2011;152:S74–S83.

35. Jensen MP. Using pain quality assessment measures for selecting analgesic agents. Clin J Pain 2005;22:S9–S13.